Psychiatry · Mood Disorders
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Bipolar disorder has the greatest genetic linkage of any psychiatric illness, with onset typically in young adults.
Bipolar I requires a manic episode lasting >= 1 week (or any duration if hospitalization is required) with elevated/expansive or irritable mood plus abnormally increased goal-directed activity or energy (both required by DSM-5-TR Criterion A), together with grandiosity, decreased need for sleep, pressured speech, and risky behavior.
Always exclude substance-induced mania with a urine drug screen for cocaine and amphetamines before diagnosis.
Lithium is the single best answer to most bipolar questions and is the mood stabilizer most consistently associated with reduced suicide risk.
Acute mania is treated with lithium, valproic acid, or an atypical antipsychotic; atypicals (olanzapine) are preferred for rapid control of severe agitation.
Bipolar depression uses lithium, quetiapine, lurasidone, or lamotrigine; avoid lithium with renal impairment and watch lamotrigine for Stevens-Johnson syndrome.
Hypomania (bipolar II) lasts >= 4 consecutive days, causes no marked functional impairment, and involves no psychosis and no hospitalization — any of which would make the episode manic by definition.
Vignette unlocked
A 21-year-old college student is brought in by his roommates after a week of unusual behavior. He has not slept in four days, talks rapidly and is difficult to interrupt, claims he will revolutionize physics, and has run up thousands of dollars in credit card charges. He is irritable and has had multiple new sexual partners this week. A urine drug screen is negative.
Which of the following is the most appropriate first-line treatment?
Lithium
A manic episode lasting at least one week with grandiosity, decreased need for sleep, pressured speech, and risky behavior, after excluding substance use, confirms bipolar I disorder. Lithium is the single best answer for most bipolar questions and additionally reduces suicide risk.
Full handout
High yield triage
Etiology / Epidemiology
Mood disorder with the greatest genetic linkage of any psychiatric illness; onset typically in young adults.
Clinical Manifestations
Mania >=1 week (elevated/irritable mood plus increased activity or energy, with grandiosity, decreased need for sleep, pressured speech, risky behavior); often begins with depression.
Diagnosis
Clinical; always exclude cocaine/amphetamine use with urine drug screen before diagnosis.
Treatment
Lithium is the answer to most bipolar questions; acute mania uses lithium, valproate, or atypical antipsychotics.
Prognosis
Chronic and recurrent with high suicide risk; lithium reduces suicidality.
Full handout
Epidemiology & Etiology
Bipolar disorder is a recurrent mood disorder that is regarded as the psychiatric illness with the greatest genetic linkage, with high heritability and frequent family history. It typically presents in young adults and is associated with increased central norepinephrine and dopamine activity and reduced serotonergic tone. The illness often begins with a depressive episode plus paradoxically increased energy and decreased sleep, which can delay correct diagnosis. Cocaine and amphetamine use can precipitate or mimic mania, so substance use must always be considered.
Pertinent Anatomy
Bipolar disorder involves dysregulation of monoaminergic circuits linking the prefrontal cortex, limbic system (amygdala), and basal ganglia that govern mood and reward. Manic states are associated with excessive central norepinephrine and dopamine signaling, with low serotonergic tone thought to permit swings in either direction (permissive hypothesis), while depressive phases reflect monoamine deficiency. Mood stabilizers such as lithium act on intracellular second-messenger systems (inositol and glycogen synthase kinase-3) within these neurons.
Pathophysiology
The disorder reflects unstable regulation of monoamine neurotransmission across limbic-cortical circuits, producing oscillation between pathologically elevated and depressed mood states. Mania is characterized by excess norepinephrine and dopamine transmission with reduced serotonergic tone (permissive hypothesis), producing heightened reward drive, explaining grandiosity, impulsivity, and decreased need for sleep, whereas the depressive pole mirrors the monoamine deficiency of major depression. Lithium and anticonvulsant mood stabilizers are thought to dampen this neuronal hyperexcitability and stabilize signal-transduction pathways.
Clinical Manifestations
The hallmark is a manic episode lasting at least 1 week with abnormally elevated, expansive, or irritable mood and abnormally increased goal-directed activity or energy (both required), plus symptoms such as inflated self-esteem/grandiosity, decreased need for sleep, pressured speech, racing thoughts, distractibility, increased goal-directed activity, and excessive involvement in pleasurable risky activities (spending sprees, hypersexuality). A classic vignette is a young college student talking fast, giggling, sleepless for days, drinking heavily, and having numerous sexual contacts. Mania severely impairs functioning and may warrant hospitalization, whereas hypomania (bipolar II) lasts >= 4 consecutive days, is less severe, and causes no marked impairment. Episodes alternate with major depression.
Diagnosis
Bipolar I is diagnosed clinically by a history of at least one manic episode (>=1 week, or any duration if hospitalization is required); bipolar II requires hypomania plus major depression without full mania. Before making the diagnosis, always rule out substance-induced mood disorder by history and a urine drug screen for cocaine and amphetamines. The distinction between mania and hypomania rests on severity, functional impairment, and duration. Cyclothymia involves >=2 years of hypomanic symptoms and mild depression.
Treatment
Distinguish acute mania from bipolar depression. For acute mania, use lithium, valproic acid, or an atypical antipsychotic; in severe agitation, atypical antipsychotics (e.g., olanzapine) are preferred for their rapid onset. For bipolar depression, use lithium, quetiapine, lurasidone, or lamotrigine; lamotrigine and certain second-generation antipsychotics are preferred over valproate in pregnancy, while valproate is contraindicated due to teratogenicity. Lithium is the single best answer to most bipolar questions and reduces suicide risk, but avoid lithium if renal function is compromised. Monitor lithium levels plus baseline and periodic renal function (creatinine/eGFR), TSH, and calcium (toxicity: confusion, ataxia, tremor) and valproate (hepatotoxicity, teratogenicity); lamotrigine carries a risk of Stevens-Johnson syndrome.
Prognosis
Bipolar disorder is a chronic, recurrent illness with episodes that tend to become more frequent over time without maintenance therapy. It carries a high lifetime risk of suicide, and lithium is the mood stabilizer most consistently associated with reduced suicidality. Long-term adherence to mood stabilizers improves the course, but nonadherence, comorbid substance use, and rapid cycling worsen outcomes. Antidepressant monotherapy should be avoided as it can precipitate a manic switch.
Differential Diagnosis
Major Depression with Psychotic Features: depression and psychosis occur together without any history of mania; presence of a prior manic episode defines bipolar.
Substance-induced mood disorder: cocaine or amphetamine intoxication mimics mania; urine drug screen positive and symptoms resolve with abstinence.
Schizoaffective Disorder: psychotic symptoms persist for >=2 weeks in the absence of a mood episode, unlike bipolar where psychosis is confined to mood episodes.
Cyclothymic Disorder: >=2 years of fluctuating hypomanic and mild depressive symptoms that never meet full criteria for a hypomanic, manic, or major depressive episode.
Borderline Personality Disorder: mood lability is rapid (hours-days) and reactive to interpersonal stress rather than sustained episodes lasting days to weeks.